Quality Control for Reference Databases in Microbial Identification
By Dr. Zubair Khalid, DVM, MS, PhD ·
Quick Answer
- Implement a scheduled database validation cycle that checks taxonomic currency, entry accuracy, and spectral or sequence quality for every reference library in active use.
- Verify suspect identifications against authenticated culture collections and official method documents before reporting results to clinicians or regulators.
- Reference database errors persist despite vendor updates, so laboratory-specific quality control is mandatory and cannot be outsourced entirely.
At a Glance
| Quality Control Domain | Key Action | Frequency | Primary Evidence Source |
|---|---|---|---|
| Taxonomic Currency | Compare database taxonomy against current nomenclature lists and official classification updates | Quarterly or before new organism panels | American Type Culture Collection |
| Spectral or Sequence Quality | Reanalyze reference spectra and sequences for noise, gaps, or mislabeled source strains | Annually or after instrument recalibration | American Society for Microbiology |
| Entry Verification | Confirm strain identity against authenticated culture collections | Before initial use and after any database update | American Type Culture Collection |
| Method Alignment | Check that database entries match current official method requirements | When new method versions are published | U.S. Food and Drug Administration Bacteriological Analytical Manual |
The Role of Reference Databases in Microbial Identification
Reference databases serve as the interpretive backbone for microbial identification systems. When a laboratory analyzes an unknown isolate using matrix-assisted laser desorption ionization time-of-flight mass spectrometry, 16S rRNA gene sequencing, or biochemical profiling, the instrument compares the observed pattern against stored reference entries. The output is only as reliable as the underlying database. A mislabeled entry, an outdated taxonomic name, or a low-quality spectrum can produce a confident but incorrect identification.
Laboratory professionals must treat reference databases as dynamic assets that require active management. The American Society for Microbiology emphasizes that professional microbiology practice depends on accurate identification methods and sound laboratory procedures. Database quality control is a core component of that professional responsibility.
The consequences of database errors extend beyond the laboratory. Misidentification can lead to incorrect antimicrobial therapy, delayed diagnosis, or inappropriate public health reporting. The World Health Organization notes that antimicrobial resistance is a global health threat, and accurate organism identification is foundational to resistance surveillance and stewardship programs. A laboratory that reports the wrong species may also report the wrong resistance profile, undermining both patient care and population-level monitoring.
Core Principles of Database Quality Control
Accuracy Begins with Authenticated Source Material
Every reference entry originates from a biological specimen that was characterized at some point in time. The quality of that original characterization determines the ceiling for database accuracy. Laboratories should acquire reference strains from authenticated culture collections such as the American Type Culture Collection, which maintains documented provenance and quality standards for biological materials. Using authenticated strains for database construction or verification reduces the risk of propagating misidentified entries.
Taxonomy Is Not Static
Microbial taxonomy changes continuously as new phylogenetic data emerge. A species name that was valid when the database was built may be reclassified, split into multiple species, or merged with another taxon. Laboratories must track these changes and update their databases accordingly. Failure to do so means the database may report outdated names that do not match current clinical or regulatory expectations.
Quality Is a Property of Each Entry
Individual entries within a database have distinct quality attributes. A spectrum may have poor resolution, a sequence may contain ambiguous base calls, or a biochemical profile may have been generated under nonstandard conditions. These entry-level quality issues can cause misidentifications even when the database as a whole is well maintained. Quality control must therefore operate at the level of individual entries, also at the database level.
Building a Database Validation Framework
Define the Scope of Validation
Before implementing quality control, the laboratory must define which databases are in scope. This includes the primary identification database, any secondary databases used for confirmation, and databases used for research or surveillance purposes. Each database may have different validation requirements based on its intended use. A database used for clinical identification requires stricter validation than one used for exploratory research.
Establish a Validation Schedule
Validation should occur on a defined schedule that includes both routine checks and event-driven checks. Routine checks occur at fixed intervals, such as quarterly or annually. Event-driven checks occur when the database is updated, when the instrument is recalibrated, or when a misidentification is suspected. The schedule should be documented in the laboratory quality manual and followed consistently.
Assign Responsibility
A named individual or team must own the database validation process. This person is responsible for executing the validation, documenting results, and escalating issues to laboratory management. Without clear ownership, validation tasks are often deferred or overlooked, especially during periods of high workload.
Checking for Taxonomic Updates
Track Nomenclature Changes
Taxonomic updates can be tracked through official culture collection catalogs, peer-reviewed taxonomic journals, and professional society communications. The American Type Culture Collection maintains current strain information and taxonomic designations for the organisms it distributes. Comparing database entries against these official records is a practical way to identify outdated names.
Update Entries with Current Names
When a taxonomic name changes, the database entry should be updated to reflect the current name. The update should preserve the original strain identifier and any associated metadata so that the entry can be traced back to its source. The update should also be documented in the laboratory records, including the date of the change and the reason for it.
Verify the Impact of Changes
A taxonomic change may affect more than the name. It may also affect the expected biochemical profile, the antimicrobial susceptibility pattern, or the clinical significance of the organism. The laboratory should review these implications when a taxonomic change is applied to the database.
Verifying Spectral and Sequence Quality
Spectral Quality Criteria
For mass spectrometry databases, spectral quality is assessed by examining the number of peaks, the signal-to-noise ratio, and the reproducibility of the spectrum. A high-quality reference spectrum should have a sufficient number of peaks to distinguish the organism from closely related species. The spectrum should be reproducible across multiple acquisitions from the same strain.
Sequence Quality Criteria
For sequence-based databases, quality is assessed by the length of the sequence, the number of ambiguous base calls, and the presence of gaps or chimeras. A high-quality reference sequence should be long enough to provide discriminating power and should have minimal ambiguity. Sequences with excessive ambiguous base calls or gaps should be flagged for review.
Reanalyzing Entries After Instrument Changes
Instrument recalibration or replacement can affect the quality of spectra generated by the instrument. After such changes, the laboratory should reanalyze a subset of reference entries to confirm that the database remains compatible with the instrument. This is particularly important for mass spectrometry databases, where spectral patterns can shift with instrument settings.
Removing Mislabeled Entries
Identifying Mislabeled Entries
Mislabeled entries can be identified through several mechanisms. A database entry that consistently produces incorrect identifications in routine use should be flagged for review. Entries that do not match the expected biochemical profile or that produce low-confidence scores should also be investigated. The laboratory should maintain a log of suspected misidentifications and review this log during the validation process.
Confirming the Mislabel
Before removing an entry, the laboratory should confirm that the entry is indeed mislabeled. This confirmation may involve reanalyzing the original strain, comparing the entry against authenticated culture collection records, or sequencing the strain to verify its identity. The American Type Culture Collection provides authenticated biological materials that can be used for this confirmation.
Removing and Replacing the Entry
Once a mislabeled entry is confirmed, it should be removed from the database and replaced with a verified entry. The removal should be documented, including the reason for removal and the date. The replacement entry should be validated using the same quality criteria applied to other entries in the database.
Verifying Database Entries Against Official Methods
Aligning with Official Method Standards
Official method standards, such as those published in the U.S. Food and Drug Administration Bacteriological Analytical Manual, define the procedures and quality requirements for food microbiology testing. When a laboratory uses a reference database for food testing, the database must align with the current method standards. This includes ensuring that the database contains entries for the organisms covered by the method and that the identification criteria match the method requirements.
Updating the Database When Methods Change
When an official method is updated, the laboratory should review the database to determine whether the update affects the identification criteria. This review should be documented and the database updated as needed. The Clinical and Laboratory Standards Institute provides standards for antimicrobial susceptibility testing, and the database should align with these standards when used for susceptibility testing.
Documenting Method Alignment
The laboratory should document the alignment between the database and the official methods in use. This documentation should include the method version, the database version, and the date of the alignment review. This documentation is essential for demonstrating compliance with quality standards.
Practical Implementation Steps
Step 1: Inventory All Databases
Create a complete inventory of all reference databases used in the laboratory. For each database, record the version, the date of the last update, the intended use, and the responsible individual. This inventory is the foundation for the validation process.
Step 2: Establish a Validation Schedule
Define a validation schedule that includes both routine and event-driven checks. The schedule should be documented and communicated to all relevant staff. The schedule should be realistic and achievable given the laboratory workload.
Step 3: Perform the Initial Validation
Conduct an initial validation of all databases in scope. This validation should include a review of taxonomic currency, spectral and sequence quality, and entry accuracy. Document the results of this initial validation and identify any entries that require correction.
Step 4: Implement Corrections
Apply the corrections identified during the validation. This includes updating taxonomic names, removing mislabeled entries, and replacing low-quality entries. Document each correction and the reason for it.
Step 5: Establish Ongoing Monitoring
Establish a process for ongoing monitoring of the database. This includes tracking taxonomic changes, reviewing new entries, and investigating suspected misidentifications. The monitoring process should be documented and reviewed regularly.
Step 6: Review and Improve the Process
Periodically review the validation process to identify areas for improvement. This review should consider the results of the validation, the number of corrections made, and any issues encountered. The process should be updated as needed to improve its effectiveness.
Records and Measurements
Documentation Requirements
The laboratory should maintain records of all database validation activities. These records should include the date of the validation, the individual who performed the validation, the databases validated, the results of the validation, and any corrections made. These records should be retained for a defined period and be available for review.
Metrics for Database Quality
The laboratory should track metrics that reflect database quality. These metrics include the number of entries updated, the number of entries removed, the number of misidentifications detected, and the time required to complete the validation. These metrics can be used to identify trends and to assess the effectiveness of the validation process.
Using Records for Continuous Improvement
The records and metrics should be used to support continuous improvement of the database and the validation process. The laboratory should review these records regularly and use them to identify areas for improvement.
Common Failure Patterns
Failure to Update the Database
A common failure pattern is the failure to update the database when taxonomic changes occur. This can result in the database reporting outdated names that do not match current clinical or regulatory expectations. This failure is often due to a lack of a defined process for tracking taxonomic changes.
Failure to Remove Mislabeled Entries
Another common failure pattern is the failure to remove mislabeled entries from the database. This can occur when the laboratory does not have a process for identifying and confirming mislabeled entries. The result is that the database continues to produce incorrect identifications.
Failure to Document the Validation Process
A third common failure pattern is the failure to document the validation process. Without documentation, the laboratory cannot demonstrate that the database has been validated, and it cannot track the effectiveness of the validation process. This failure can have regulatory and accreditation implications.
Failure to Align with Official Methods
A fourth common failure pattern is the failure to align the database with official method standards. This can occur when the laboratory does not review the database when method standards are updated. The result is that the database may not be suitable for the intended use.
Limitations and Interpretation
Database Quality Does Not Guarantee Identification Accuracy
Even a well-maintained database cannot guarantee that every identification will be accurate. The database is one component of the identification process, and other factors, such as the quality of the sample and the skill of the analyst, also affect the accuracy of the identification. The laboratory should interpret database results in the context of the entire identification process.
The Database Is a Snapshot in Time
A database is a snapshot of the microbial taxonomy and spectral or sequence data at a particular point in time. As new species are discovered and as the taxonomy changes, the database becomes outdated. The laboratory must recognize this limitation and implement a process for regular updates.
The Database Is Not a Substitute for Professional Judgment
The database is a tool that supports professional judgment, but it is not a substitute for it. The laboratory professional must interpret the database results in the context of the sample, the clinical presentation, and the laboratory findings. The database should be used as one piece of evidence in the identification process.
Biosafety and Containment Considerations
Handling Reference Strains
Reference strains used for database validation should be handled in accordance with the biosafety level appropriate for the organism. The CDC and NIH Biosafety in Microbiological and Biomedical Laboratories provides guidance on risk assessment, containment, and decontamination. The laboratory should follow this guidance when handling reference strains.
Decontamination of Equipment
Equipment used for database validation, such as mass spectrometers and sequencers, should be decontaminated according to the manufacturer instructions and the laboratory biosafety procedures. The CDC and NIH Biosafety in Microbiological and Biomedical Laboratories provides guidance on decontamination practices.
Waste Management
Waste generated during database validation, such as culture plates and sample tubes, should be managed according to the laboratory biosafety procedures. The CDC and NIH Biosafety in Microbiological and Biomedical Laboratories provides guidance on waste management.
Professional Escalation Criteria
When to Escalate a Database Issue
The laboratory should escalate a database issue when the issue cannot be resolved through the routine validation process. This includes issues that affect the accuracy of clinical identifications, issues that involve a large number of entries, or issues that require the expertise of a specialist.
When to Contact the Database Vendor
The laboratory should contact the database vendor when the issue is related to the database software or when the laboratory cannot resolve the issue internally. The vendor may be able to provide a correction or an update to the database.
When to Contact a Reference Laboratory
The laboratory should contact a reference laboratory when the issue involves an organism that the laboratory cannot identify with confidence. The reference laboratory may be able to provide a definitive identification using additional methods.
When to Contact the Public Health Authority
The laboratory should contact the public health authority when the issue involves a reportable organism or when the issue has public health implications. The public health authority can provide guidance on the appropriate response.
A Practical Decision Framework for Database Entry Disposition
Laboratory managers face a recurring operational problem that standard validation checklists do not solve: what to do with a specific database entry that fails a quality check. The decision to update, quarantine, remove, or replace an entry carries consequences for workload, result turnaround time, and regulatory compliance. A structured decision framework converts subjective judgment into a repeatable process that any trained analyst can apply consistently.
The Four Disposition Outcomes
Every database entry that fails a quality check should be assigned one of four dispositions: retain with documentation, quarantine, correct and restore, or remove and replace. These dispositions form the core of a practical decision framework because they force the laboratory to make an explicit choice about each problematic entry instead of leaving it in an ambiguous state.
Retain with documentation applies when the entry passes all critical quality checks but has a minor issue that does not affect identification accuracy. An example is a reference spectrum with slightly elevated baseline noise that still produces correct identifications in validation testing. The entry remains active, but the issue is documented in the quality record and scheduled for re-evaluation at the next validation cycle.
Quarantine applies when the entry may be incorrect but the laboratory cannot confirm the problem within a defined time frame. The entry is removed from the active identification database and placed in a separate quarantine file. Quarantined entries are not used for routine identifications. The quarantine file preserves the entry data for investigation without allowing it to influence patient or product results.
Correct and restore applies when the entry has a fixable defect. A spectrum with a mislabeled strain identifier can be corrected if the original strain is available and the spectrum is otherwise valid. A sequence with a small number of ambiguous base calls may be reanalyzed and corrected. The corrected entry is revalidated and then restored to the active database.
Remove permanently applies when the entry is confirmed as mislabeled, when the source strain is no longer available for verification, or when the entry cannot be corrected to acceptable quality. Permanent removal is also appropriate when the entry represents a taxon that is no longer recognized or when the entry has been superseded by a higher-quality replacement.
The Decision Tree for Entry Disposition
The decision framework operates as a structured sequence of questions. Each question has a binary answer that directs the analyst to the next step. This structure prevents subjective judgment from dominating the process and ensures that different analysts reach the same disposition for the same entry.
Question 1: Does the entry pass the critical quality checks?
The critical checks are the minimum requirements for any entry to remain in the active database. For spectral entries, these checks include a minimum number of reproducible peaks, an acceptable signal-to-noise ratio, and a match between the entry metadata and the source strain record. For sequence entries, the critical checks include sequence length, the number of ambiguous base calls, and the absence of chimeras or vector contamination. If the entry fails any critical check, proceed to Question 2. If the entry passes all critical checks, proceed to Question 3.
Question 2: Can the problem be corrected within a defined time frame?
The laboratory should define a correction time frame, typically 30 days, before the validation cycle begins. If the problem can be corrected within that time frame, assign the entry to the correct and restore disposition. If the problem cannot be corrected within the time frame, assign the entry to the quarantine disposition. The time frame prevents indefinite delays and forces a decision.
Question 3: Does the entry match the current taxonomic designation?
The entry must be compared against the current taxonomy for the organism. This comparison uses the American Type Culture Collection catalog and other official taxonomic records. If the entry name is outdated, the laboratory must determine whether the name change is a simple synonym or a substantive reclassification. A simple synonym can be updated in place. A substantive reclassification may require additional verification because the organism may have different clinical or biochemical characteristics under the new classification. If the entry does not match current taxonomy and cannot be updated, proceed to Question 4.
Question 4: Is the entry identity confirmed by an independent method?
The laboratory must have independent confirmation of the entry identity. This confirmation may come from an authenticated culture collection record, from a reference laboratory identification, or from a second method such as sequencing when the entry is a spectral entry. If the identity is confirmed, the entry can be updated and retained. If the identity cannot be confirmed, the entry is assigned to the remove permanently disposition.
Implementing the Decision Framework
The decision framework is implemented through a structured workflow that integrates with the laboratory quality management system. The workflow begins when a database entry is flagged during routine validation, during an event-driven check, or after a suspected misidentification in routine use.
Step 1: Flag the entry. The analyst records the entry identifier, the database name, the date, and the reason for the flag. The reason must be specific. A general note that the entry looks wrong is not sufficient. The analyst must state the specific quality issue, such as low spectral score, ambiguous sequence base calls, or a name that does not match the current taxonomy.
Step 2: Apply the decision framework. The analyst works through the four questions in order. Each answer is recorded in the quality record. The disposition is assigned based on the answers.
Step 3: Execute the disposition. The analyst performs the actions required for the assigned disposition. For quarantine, the entry is moved to the quarantine directory and the active database is updated. For correct and restore, the correction is performed and the entry is revalidated. For remove permanently, the entry is deleted from the active database and the deletion is documented.
Step 4: Document the outcome. The disposition, the date, the analyst name, and the reason are recorded in the database quality log. The log is reviewed by the laboratory supervisor or quality manager at the next quality review meeting.
Step 5: Review the disposition. The laboratory supervisor reviews the disposition decisions at a defined frequency, typically monthly. The review confirms that the framework was applied correctly and that no entry was removed or quarantined without adequate justification.
The Quarantine Process in Detail
The quarantine disposition requires a defined process because it is the most operationally complex option. A quarantined entry is not deleted, but it is also not available for identification. The quarantine process must be documented so that the laboratory can track quarantined entries and resolve them within a defined time.
The quarantine directory is a separate location from the active database. The entry is moved to this directory with its full metadata, including the original source strain identifier, the date of quarantine, and the reason for quarantine. The active database is updated to remove the entry from the identification pool. The quarantine directory is backed up with the same frequency as the active database.
The laboratory defines a quarantine review schedule. A common schedule is a 90-day review cycle. At each review, the laboratory attempts to resolve the quarantine. The resolution may be a correction, a permanent removal, or an extension of the quarantine with a documented justification. A quarantine that remains unresolved after two review cycles should be escalated to the laboratory supervisor or the database vendor.
The quarantine system is particularly important for laboratories that use the database for clinical or regulatory identification. A quarantined entry cannot produce a misidentification because it is not available for comparison. The quarantine system therefore provides a safety net between the time a problem is detected and the time the problem is resolved.
The Correction and Restoration Process
The correct and restore disposition requires a defined correction process. The correction must be performed by a qualified analyst and must be verified before the entry is restored to the active database.
The correction process begins with the identification of the specific problem. A spectrum with a mislabeled sample is corrected by updating the metadata to match the authenticated strain record. A sequence with ambiguous base calls is corrected by reanalyzing the original sequence data or by resequencing the strain. A biochemical profile with a nonstandard result is corrected by repeating the biochemical tests under standard conditions.
After the correction is applied, the entry is revalidated using the same quality criteria that apply to new entries. The revalidation includes a comparison against authenticated reference material. The American Type Culture Collection provides authenticated strains that can be used for this comparison. The revalidated entry is then restored to the active database with a new version number and a record of the correction.
The correction process must be documented in the database quality log. The documentation includes the original problem, the correction applied, the revalidation results, and the date of the restoration. This documentation is essential for demonstrating that the correction was performed correctly and that the entry is now suitable for use.
The Removal and Replacement
The remove permanently disposition is the most consequential decision in the framework. A permanent removal should only be made when the entry cannot be corrected or verified. The removal must be documented with the reason and the evidence supporting the decision.
The removal process includes the deletion of the entry from the active database and the creation of a permanent record of the removal. The permanent record includes the original entry data, the reason for removal, the date of removal, and the name of the individual who made the decision. The permanent record is retained for the same period as other database quality records.
The replacement of a removed entry is a separate decision. The laboratory may choose to replace the entry with a new entry from an authenticated source, or the laboratory may choose to leave the entry absent from the database. The replacement decision is based on the need for the entry in the laboratory identification workflow. If the entry represents an organism that the laboratory identifies regularly, a replacement entry should be acquired and validated. If the entry represents an organism that is rarely encountered, the laboratory may choose to leave the entry absent and rely on the identification process to flag the organism as not in the database.
The Role of the Decision Framework in the Validation Cycle
The decision framework is not a replacement for the validation cycle. It is a component of the validation cycle that provides a structured method for handling entries that fail validation. The framework is applied during the routine validation checks and during event-driven checks.
The framework also supports the continuous improvement process. The disposition records provide data on the types of problems that occur in the database. The laboratory can analyze these records to identify patterns. A high number of quarantine dispositions may indicate that the database vendor is not maintaining the database adequately. A high number of correct and restore dispositions may indicate that the laboratory is not following the correct procedures for adding new entries. These patterns can be used to improve the database management process.
Records and Measurements for the Decision Framework
The decision framework requires specific records and measurements to be effective. The laboratory must maintain a database quality log that records every disposition decision. The log includes the entry identifier, the reason for the flag, the disposition assigned, the date of the decision, and the name of the analyst.
The laboratory should track the following metrics for the decision framework:
Disposition rate. The number of entries assigned to each disposition in a validation cycle. This metric shows the overall health of the database. A high removal rate may indicate a systemic problem with the database source or the laboratory entry creation process.
Quarantine resolution time. The time from the quarantine assignment to the resolution of the quarantine. This metric shows whether the laboratory is resolving quarantined entries in a timely manner. A long quarantine time may indicate that the laboratory does not have the resources to resolve the entries.
Correction success rate. The percentage of corrected entries that pass revalidation. This metric shows whether the correction process is effective. A low success rate may indicate that the correction process is not addressing the root cause of the problem.
Removal justification rate. The percentage of removed entries that have a documented justification. This metric shows whether the removal process is being followed correctly. A low justification rate may indicate that entries are being removed without adequate documentation.
Common Failure Patterns in the Decision Framework
The decision framework can fail in several ways. The most common failure pattern is the indefinite quarantine. The laboratory quarantines an entry but does not resolve the quarantine within the defined time. The entry remains in quarantine indefinitely, and the laboratory loses track of the reason for the quarantine. This failure is prevented by the defined quarantine time and the escalation process.
A second failure pattern is the correction without revalidation. The laboratory corrects an entry but does not revalidate the corrected entry. The corrected entry is restored to the database without verification. This failure is prevented by the requirement that all corrected entries are revalidated before restoration.
A third failure pattern is the removal without documentation. The laboratory removes an entry but does not document the reason for the removal. The removal is not traceable, and the laboratory cannot demonstrate that the removal was justified. This failure is prevented by the requirement that all removals are documented in the database quality log.
A fourth failure pattern is the application of the framework to the wrong entry. The analyst flags the wrong entry or applies the framework to an entry that does not have a quality problem. This failure is prevented by the requirement that the flag reason is specific and that the analyst works through the framework questions in order.
Professional Escalation Criteria for the Decision Framework
The decision framework includes specific escalation criteria. The laboratory should escalate a decision when the disposition is not clear from the framework. This may occur when the entry has multiple quality issues that affect the decision or when the entry is a rare organism that the laboratory does not have the expertise to evaluate.
The laboratory should escalate to the database vendor when the entry is part of a vendor-supplied database and the vendor has not provided a correction. The vendor may be able to provide a corrected entry or a new version of the database. The laboratory should escalate to a reference laboratory when the entry is a rare organism and the laboratory cannot confirm the identity. The reference laboratory may be able to provide a definitive identification.
The laboratory should escalate to the public health authority when the entry is a reportable organism or when the entry has public health implications. The public health authority can provide guidance on the appropriate response to the entry.
Biosafety and Containment Considerations
The decision framework involves the handling of reference strains and the use of laboratory equipment. The laboratory must follow the biosafety requirements for the organisms being handled. The CDC and NIH Biosafety in Microbiological and Biomedical Laboratories provides guidance on risk assessment, containment, and decontamination. The laboratory should follow this guidance when handling reference strains for the correction and restoration process.
The correction process may require the reanalysis of the original strain. The strain is handled according to the biosafety level appropriate for the organism. The equipment used for the reanalysis is decontaminated according to the manufacturer instructions and the laboratory biosafety procedures. The waste generated during the correction process is managed according to the laboratory biosafety procedures.
Professional Escalation Criteria
The laboratory should escalate a decision framework issue when the issue cannot be resolved through the routine process. This includes issues that affect the accuracy of clinical identifications, issues that involve a large number of entries, or issues that require the expertise of a specialist.
The laboratory should contact the database vendor when the issue is related to the database software or when the laboratory cannot resolve the issue internally. The vendor may be able to provide a correction or an update to the database.
The laboratory should contact a reference laboratory when the issue involves an organism that the laboratory cannot identify with confidence. The reference laboratory may be able to provide a definitive identification using additional methods.
The laboratory should contact the public health authority when the issue involves a reportable organism or when the issue has public health implications. The public health authority can provide guidance on the appropriate response.
Frequently Asked Questions
How often should a reference database be validated?
The validation frequency depends on the database use and the rate of taxonomic change. A quarterly review of taxonomic currency is a reasonable starting point, with annual full validation of spectral or sequence quality. Event-driven validation should occur after instrument recalibration or when a misidentification is suspected.
What is the difference between a database update and a database validation?
A database update is the process of adding new entries or changing existing entries. A database validation is the process of checking the accuracy and quality of the entries. An update does not guarantee that the database is accurate, so validation is a separate and essential step.
How can a laboratory identify a mislabeled entry?
A mislabeled entry can be identified by comparing the database entry against authenticated culture collection records, by reanalyzing the original strain, or by sequencing the entry to verify its identity. The American Type Culture Collection provides authenticated biological materials for this purpose.
What should be done when a database entry is found to be mislabeled?
The entry should be removed from the database and replaced with a verified entry. The removal and replacement should be documented, including the reason for the removal and the date of the change.
How does a laboratory ensure that the database is aligned with official methods?
The laboratory should review the database when official method standards are updated. The U.S. Food and Drug Administration Bacteriological Analytical Manual provides official method standards for food microbiology, and the Clinical and Laboratory Standards Institute provides standards for antimicrobial susceptibility testing.
What are the biosafety considerations for database validation?
The laboratory should handle reference strains according to the biosafety level appropriate for the organism. The CDC and NIH Biosafety in Microbiological and Biomedical Laboratories provides guidance on risk assessment, containment, and decontamination.
How should the laboratory document the database validation process?
The laboratory should maintain records of the validation date, the databases validated, the results of the validation, and any corrections made. These records should be available for review and should be used to track the effectiveness of the validation process.
When should a laboratory escalate a database issue?
The laboratory should escalate a database issue when the issue cannot be resolved within the routine validation process, when the issue affects the accuracy of clinical identifications, or when the issue requires the expertise of a specialist or the public health authority.
Using the Evidence
| Source | Best use in this topic | Important limitation |
|---|---|---|
| Biosafety in Microbiological and Biomedical Laboratories | official guidance | Check the linked page for current local requirements |
| Microbiology Resources | official guidance | Check the linked page for current local requirements |
| Antimicrobial Resistance | official guidance | Check the linked page for current local requirements |
Related Diagnostic Guides
- Hematology Quality Control: Ensuring Accuracy in Automated Analyzers
- MALDI-TOF Mass Spectrometry for Veterinary Microbial Identification
- Microbiology Quality Control: Essential Practices for Reliable Culture Results
References and Further Reading
- Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
- Microbiology Resources. American Society for Microbiology.
- Antimicrobial Resistance. World Health Organization.
- Bacteriological Analytical Manual. U.S. Food and Drug Administration.
- Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute.
- Culture Collections. American Type Culture Collection.
- Laboratory Biosafety Manual. World Health Organization.
- NCBI Literature Resources. National Center for Biotechnology Information.
- gcType: a high-quality type strain genome database for microbial phylogenetic and functional research.. Nucleic acids research, 2021.
- FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science.. Nature communications, 2019.
- Establishing quality control ranges for antimicrobial susceptibility testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: a cornerstone to develop reference strains for Korean clinical microbiology laboratories.. Annals of laboratory medicine, 2015.
This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.